Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_assertion description "[They have represented a paradigm of molecular-targeted therapies for solid tumors since the discovery of KIT mutations and KIT expression in GIST in 1998, which opened the way to the use of imatinib, a tyrosine kinase inhibitor able to inhibit the growth of cells expressing KIT-mutant isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_assertion evidence source_evidence_literature NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_assertion SIO_000772 23975171 NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_assertion wasDerivedFrom befree-2016 NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_assertion wasGeneratedBy ECO_0000203 NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.
- befree-2016 importedOn "2016-02-19" NP1105069.RA9O68zkAxdenEFl1t2PluXx5HCLIB9VSIHcizRqcz-7A130_provenance.